Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases
Histopathology · 2024
DOI: 10.1111/his.15217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Melad N Dababneh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Carcinoma, Squamous Cell, Immunophenotyping, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and aims Salivary duct carcinoma (SDC) is an aggressive salivary malignancy with multiple morphological subtypes. Primary salivary squamous cell carcinoma (SCC) requires exclusion of high‐grade salivary malignancies and metastatic disease and is considered exceptionally rare. We report six cases of SDC with resemblance to SCC on account of variable, but often extensive, squamous differentiation. Methods and results A retrospective review (2009–2023) at two institutions of SDC with histological and immunophenotypical evidence of squamous differentiation identified six cases. Medical charts and available glass slides were reviewed. There were five males and one female with a median age of 63 years, with tumours involving the parotid (five of six) and submandibular (one of six) glands. All six tumours showed a conventional SDC component comprising < 5–90% of viable tumour. Squamous differentiation comprised 10–95%+ (> 75% in three of six cases) of total viable tumour, and demonstrated CK5/6, p63 and/or p40 immunoexpression in all cases. A sarcomatoid component, comprising 10–60% of viable tumour, was present in three of six (50%) cases. All tumours were androgen receptor (AR)‐positive, but only two of six (33.3%) retained AR immunoreactivity in the squamous component. Metastatic SDC to regional lymph nodes exhibited exclusive squamous differentiation in two of six (33.3%) cases. Conclusion Squamous differentiation, histologically and immunophenotypically, can be extensive in SDC. AR expression may be lost in the squamous component and metastases may demonstrate only squamous differentiation. These findings cast further doubt on the existence of primary salivary SCC. SDC should be considered whenever encountering a carcinoma with squamous differentiation in major salivary glands or within cervical lymph nodes in the setting of a salivary mass.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
ORCID-Profile: Melad N Dababneh, Christopher C Griffith, Ivan J Stojanov
Zitieren
APA
Dababneh, M. N., Griffith, C. C., Magliocca, K. R., & Stojanov, I. J. (2024). Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases. Histopathology. https://doi.org/10.1111/his.15217
Vancouver
Dababneh MN, Griffith CC, Magliocca KR, Stojanov IJ. Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases. Histopathology. 2024. doi:10.1111/his.15217
BibTeX
@article{Dababneh2024,
author = {Dababneh, Melad N and Griffith, Christopher C and Magliocca, Kelly R and Stojanov, Ivan J},
title = {Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases},
journal = {Histopathology},
year = {2024},
doi = {10.1111/his.15217}
}
EUVIMED